• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

无赖氨酸HiBiT和纳米荧光素酶标记系统作为监测靶向蛋白质降解的替代工具。

Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools for Monitoring Targeted Protein Degradation.

作者信息

Lin Hanfeng, Riching Kristin, Lai May Poh, Lu Dong, Cheng Ran, Qi Xiaoli, Wang Jin

机构信息

The Verna and Marrs McLean Department of Biochemistry and Molecular Pharmacology, Baylor College of Medicine, Houston, Texas 77030, United States.

Center for NextGen Therapeutics, Baylor College of Medicine, Houston, Texas 77030, United States.

出版信息

ACS Med Chem Lett. 2024 Jul 28;15(8):1367-1375. doi: 10.1021/acsmedchemlett.4c00271. eCollection 2024 Aug 8.

DOI:10.1021/acsmedchemlett.4c00271
PMID:39140070
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11318018/
Abstract

Target protein degradation (TPD) has emerged as a revolutionary approach in drug discovery, leveraging the cell's intrinsic machinery to selectively degrade disease-associated proteins. Nanoluciferase (nLuc) fusion proteins and the NanoBiT technology offer two robust and sensitive screening platforms to monitor the subtle changes in protein abundance induced by TPD molecules. Despite these advantages, concerns have arisen regarding potential degradation artifacts introduced by tagging systems due to the presence of lysine residues on them, prompting the development of alternative tools. In this study, we introduce HiBiT-RR and nLuc, variants devoid of lysine residues, to mitigate such artifacts. Our findings demonstrate that HiBiT-RR maintains a similar sensitivity and binding affinity with the original HiBiT. Moreover, the comparison between nLuc and nLuc constructs reveals variations in degradation patterns induced by certain TPD molecules, emphasizing the importance of choosing appropriate tagging systems to ensure the reliability of experimental outcomes in studying protein degradation processes.

摘要

靶向蛋白降解(TPD)已成为药物发现中的一种革命性方法,它利用细胞的内在机制来选择性降解与疾病相关的蛋白质。纳米荧光素酶(nLuc)融合蛋白和纳米生物发光技术(NanoBiT)提供了两个强大且灵敏的筛选平台,以监测TPD分子诱导的蛋白质丰度的细微变化。尽管有这些优点,但由于标记系统上存在赖氨酸残基,人们对其可能引入的潜在降解假象产生了担忧,这促使了替代工具的开发。在本研究中,我们引入了不含赖氨酸残基的变体HiBiT-RR和nLuc,以减轻此类假象。我们的研究结果表明,HiBiT-RR与原始HiBiT保持相似的灵敏度和结合亲和力。此外,nLuc与nLuc构建体之间的比较揭示了某些TPD分子诱导的降解模式的差异,强调了选择合适的标记系统以确保在研究蛋白质降解过程中实验结果可靠性的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/38480e01ccfb/ml4c00271_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/b8bd91489bd1/ml4c00271_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/10711a5c3f9a/ml4c00271_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/88f6db6ca43a/ml4c00271_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/9f92f251946a/ml4c00271_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/38480e01ccfb/ml4c00271_0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/b8bd91489bd1/ml4c00271_0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/10711a5c3f9a/ml4c00271_0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/88f6db6ca43a/ml4c00271_0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/9f92f251946a/ml4c00271_0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d14c/11318018/38480e01ccfb/ml4c00271_0005.jpg

相似文献

1
Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools for Monitoring Targeted Protein Degradation.无赖氨酸HiBiT和纳米荧光素酶标记系统作为监测靶向蛋白质降解的替代工具。
ACS Med Chem Lett. 2024 Jul 28;15(8):1367-1375. doi: 10.1021/acsmedchemlett.4c00271. eCollection 2024 Aug 8.
2
Lysineless HiBiT and NanoLuc Tagging Systems as Alternative Tools Monitoring Targeted Protein Degradation.无赖氨酸HiBiT和纳米荧光素酶标记系统作为监测靶向蛋白质降解的替代工具。
bioRxiv. 2024 May 17:2024.05.14.594249. doi: 10.1101/2024.05.14.594249.
3
HiBiT Cellular Thermal Shift Assay (HiBiT CETSA).HiBiT 细胞热转移分析(HiBiT CETSA)。
Methods Mol Biol. 2023;2706:149-165. doi: 10.1007/978-1-0716-3397-7_11.
4
Probing expression of E-selectin using CRISPR-Cas9-mediated tagging with HiBiT in human endothelial cells.利用CRISPR-Cas9介导的HiBiT标记技术在人内皮细胞中探究E-选择素的表达。
iScience. 2023 Jun 30;26(7):107232. doi: 10.1016/j.isci.2023.107232. eCollection 2023 Jul 21.
5
Generation of recombinant rotaviruses encoding a split NanoLuc peptide tag.生成编码分段 NanoLuc 肽标签的重组轮状病毒。
Biochem Biophys Res Commun. 2021 Jan 1;534:740-746. doi: 10.1016/j.bbrc.2020.11.007. Epub 2020 Nov 26.
6
CRISPR-Cas9-Mediated Bioluminescent Tagging of Endogenous Proteins by Fluorescent Protein-Assisted Cell Sorting.通过荧光蛋白辅助细胞分选对内源性蛋白进行 CRISPR-Cas9 介导的生物发光标记。
Methods Mol Biol. 2024;2779:273-286. doi: 10.1007/978-1-0716-3738-8_12.
7
Application of a novel HiBiT peptide tag for monitoring ATF4 protein expression in Neuro2a cells.一种新型HiBiT肽标签在监测Neuro2a细胞中ATF4蛋白表达的应用。
Biochem Biophys Rep. 2017 Aug 15;12:40-45. doi: 10.1016/j.bbrep.2017.08.002. eCollection 2017 Dec.
8
Integration of HiBiT into enteroviruses: A universal tool for advancing enterovirus virology research.将 HiBiT 整合到肠道病毒中:推进肠道病毒病毒学研究的通用工具。
Virol Sin. 2024 Jun;39(3):422-433. doi: 10.1016/j.virs.2024.03.004. Epub 2024 Mar 16.
9
NanoBiT Complementation to Monitor Agonist-Induced Adenosine A Receptor Internalization.利用 NanoBiT 互补技术监测激动剂诱导的腺苷 A 受体内化。
SLAS Discov. 2020 Feb;25(2):186-194. doi: 10.1177/2472555219880475. Epub 2019 Oct 4.
10
Novel assays to monitor gene expression and protein-protein interactions in rice using the bioluminescent protein, NanoLuc.利用生物发光蛋白NanoLuc监测水稻基因表达和蛋白质-蛋白质相互作用的新型检测方法。
Plant Biotechnol (Tokyo). 2021 Mar 25;38(1):89-99. doi: 10.5511/plantbiotechnology.20.1209a.

引用本文的文献

1
Development of Degraders and 2-pyridinecarboxyaldehyde (2-PCA) as a recruitment Ligand for FBXO22.降解剂的开发以及2-吡啶甲醛(2-PCA)作为FBXO22的募集配体
bioRxiv. 2025 Aug 20:2025.08.19.671158. doi: 10.1101/2025.08.19.671158.
2
One Tracer, Dual Platforms: Unlocking Versatility of Fluorescent Probes in TR-FRET and NanoBRET Target Engagement Assays.一种示踪剂,两种平台:在时间分辨荧光共振能量转移(TR-FRET)和纳米荧光共振能量转移(NanoBRET)靶点结合分析中解锁荧光探针的多功能性
ACS Med Chem Lett. 2025 Jul 7. doi: 10.1021/acsmedchemlett.5c00171.
3
Beyond the G-Loop: CRBN Molecular Glues Potently Target VAV1 via a Novel SH3 RT-Loop Degron.

本文引用的文献

1
Development of Biochemical and Cellular Probes to Study RIPK1 Target Engagement.用于研究RIPK1靶点结合的生化和细胞探针的开发。
ACS Med Chem Lett. 2024 May 10;15(6):906-916. doi: 10.1021/acsmedchemlett.4c00104. eCollection 2024 Jun 13.
2
Cullin-RING ligases employ geometrically optimized catalytic partners for substrate targeting.Cullin-RING 连接酶采用几何优化的催化伙伴进行底物靶向。
Mol Cell. 2024 Apr 4;84(7):1304-1320.e16. doi: 10.1016/j.molcel.2024.01.022. Epub 2024 Feb 20.
3
Kinase-impaired BTK mutations are susceptible to clinical-stage BTK and IKZF1/3 degrader NX-2127.
超越G环:CRBN分子胶通过一种新型SH3 RT环降解子有效靶向VAV1。
bioRxiv. 2025 Jun 9:2025.06.08.658535. doi: 10.1101/2025.06.08.658535.
4
One Tracer, Dual Platforms: Unlocking Versatility of Fluorescent Probes in TR-FRET and NanoBRET Target Engagement Assays.一种示踪剂,两种平台:在时间分辨荧光共振能量转移(TR-FRET)和纳米生物发光共振能量转移(NanoBRET)靶点结合分析中释放荧光探针的多功能性
bioRxiv. 2025 Mar 27:2025.03.24.645143. doi: 10.1101/2025.03.24.645143.
5
Rapid and high-throughput screening of proteolysis targeting chimeras using a dual-reporter system expressing fluorescence protein and luciferase.使用表达荧光蛋白和荧光素酶的双报告系统对靶向嵌合体的蛋白水解进行快速高通量筛选。
BMC Biol. 2025 Feb 21;23(1):51. doi: 10.1186/s12915-025-02153-7.
6
Luciferase complementation for cellular assays beyond protein-protein interactions.用于细胞分析的荧光素酶互补技术,超越蛋白质-蛋白质相互作用。
Anal Sci. 2025 May;41(5):571-583. doi: 10.1007/s44211-025-00730-y. Epub 2025 Feb 18.
7
Four-color single-molecule imaging system for tracking GPCR dynamics with fluorescent HiBiT peptide.用于通过荧光HiBiT肽追踪GPCR动态的四色单分子成像系统。
Biophys Physicobiol. 2024 Sep 20;21(3):e210020. doi: 10.2142/biophysico.bppb-v21.0020. eCollection 2024.
8
Application of Fluorescence- and Bioluminescence-Based Biosensors in Cancer Drug Discovery.基于荧光和生物发光的生物传感器在癌症药物发现中的应用。
Biosensors (Basel). 2024 Nov 24;14(12):570. doi: 10.3390/bios14120570.
9
Suite of Biochemical and Cell-Based Assays for the Characterization of Kirsten Rat Sarcoma (KRAS) Inhibitors and Degraders.用于表征 Kirsten 大鼠肉瘤(KRAS)抑制剂和降解剂的一系列生化和基于细胞的分析方法
ACS Pharmacol Transl Sci. 2024 Dec 2;7(12):3921-3934. doi: 10.1021/acsptsci.4c00450. eCollection 2024 Dec 13.
10
Covalent Proximity Inducers.共价接近诱导剂
Chem Rev. 2025 Jan 8;125(1):326-368. doi: 10.1021/acs.chemrev.4c00570. Epub 2024 Dec 18.
激酶结构域缺失的 BTK 突变易受临床阶段 BTK 和 IKZF1/3 降解剂 NX-2127 的影响。
Science. 2024 Feb 2;383(6682):eadi5798. doi: 10.1126/science.adi5798.
4
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton's Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies.发现和临床前药理学研究 NX-2127,一种口服生物可利用的布鲁顿酪氨酸激酶降解剂,具有免疫调节活性,用于治疗 B 细胞恶性肿瘤患者。
J Med Chem. 2024 Feb 22;67(4):2321-2336. doi: 10.1021/acs.jmedchem.3c01007. Epub 2024 Feb 1.
5
Annual review of PROTAC degraders as anticancer agents in 2022.2022 年 PROTAC 降解剂作为抗癌药物的年度回顾。
Eur J Med Chem. 2024 Mar 5;267:116166. doi: 10.1016/j.ejmech.2024.116166. Epub 2024 Jan 25.
6
Machine Learning Modeling of Protein-intrinsic Features Predicts Tractability of Targeted Protein Degradation.基于蛋白质内在特性的机器学习模型预测靶向蛋白降解的可处理性。
Genomics Proteomics Bioinformatics. 2022 Oct;20(5):882-898. doi: 10.1016/j.gpb.2022.11.008. Epub 2022 Dec 6.
7
NRX-0492 degrades wild-type and C481 mutant BTK and demonstrates in vivo activity in CLL patient-derived xenografts.NRX-0492 降解野生型和 C481 突变 BTK ,并在 CLL 患者来源异种移植模型中显示体内活性。
Blood. 2023 Mar 30;141(13):1584-1596. doi: 10.1182/blood.2022016934.
8
Predicting the structural basis of targeted protein degradation by integrating molecular dynamics simulations with structural mass spectrometry.通过将分子动力学模拟与结构质谱相结合,预测靶向蛋白质降解的结构基础。
Nat Commun. 2022 Oct 6;13(1):5884. doi: 10.1038/s41467-022-33575-4.
9
The importance of cellular degradation kinetics for understanding mechanisms in targeted protein degradation.细胞降解动力学在理解靶向蛋白降解机制中的重要性。
Chem Soc Rev. 2022 Jul 18;51(14):6210-6221. doi: 10.1039/d2cs00339b.
10
A direct high-throughput protein quantification strategy facilitates discovery and characterization of a celastrol-derived BRD4 degrader.一种直接的高通量蛋白质定量策略促进了雷公藤红素衍生的 BRD4 降解剂的发现和表征。
Cell Chem Biol. 2022 Aug 18;29(8):1333-1340.e5. doi: 10.1016/j.chembiol.2022.05.003. Epub 2022 May 31.